Literature DB >> 22846800

DDB2 is a novel AR interacting protein and mediates AR ubiquitination/degradation.

Szu-Wei Chang1, Chieh-Hao Su, Hsuan-Hao Chen, Chu-Wei Huang, Li-Pen Tsao, Yeou-Ping Tsao, Show-Li Chen.   

Abstract

Damaged DNA-binding protein 2 (DDB2), a protein that binds damaged DNA, is a DDB1 and CUL4-associated factor. This study is the first to demonstrate that DDB2 is a novel androgen receptor (AR)-interacting protein; and mediating contact with AR and CUL4A-DDB1 complex for AR ubiquitination/degradation. DNA damage induces both p53 and DDB2 gene expression those two can inhibit AR expression. The former reduces AR via transcription regulation but the latter via proteosome degradation. Thereby DDB2 can inhibit cell growth rate in AR-expressing cells (LNCaP) but not in AR-null cells (PC3). Hence DDB2 may be a potential regimen for prostate cancer treatment, especially in androgen-refractory patients harboring high amount of AR who cannot be cured by androgen ablation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22846800     DOI: 10.1016/j.biocel.2012.07.023

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  10 in total

1.  Hypoxia-inducible CircPFKFB4 Promotes Breast Cancer Progression by Facilitating the CRL4DDB2 E3 Ubiquitin Ligase-mediated p27 Degradation.

Authors:  Hang Chen; Rui Yang; Lei Xing; Bin Wang; Dawei Liu; Xiaoqiang Ou; Yumei Deng; Rong Jiang; Junxia Chen
Journal:  Int J Biol Sci       Date:  2022-06-06       Impact factor: 10.750

2.  BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability.

Authors:  P-C Kuo; C-W Huang; C-I Lee; H-W Chang; S-W Hsieh; Y-P Chung; M-S Lee; C-S Huang; L-P Tsao; Y-P Tsao; S-L Chen
Journal:  Br J Cancer       Date:  2014-12-02       Impact factor: 7.640

3.  Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer.

Authors:  Emmanuelle Nicolas; Sanjeevani Arora; Yan Zhou; Ilya G Serebriiskii; Mark D Andrake; Elizabeth D Handorf; Dale L Bodian; Joseph G Vockley; Roland L Dunbrack; Eric A Ross; Brian L Egleston; Michael J Hall; Erica A Golemis; Veda N Giri; Mary B Daly
Journal:  Oncotarget       Date:  2015-11-24

4.  NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.

Authors:  Hsin-Hsiung Chen; Ping Fan; Szu-Wei Chang; Yeou-Ping Tsao; Hsiang-Po Huang; Show-Li Chen
Journal:  Oncotarget       Date:  2017-03-28

5.  Regulation of liver receptor homologue-1 by DDB2 E3 ligase activity is critical for hepatic glucose metabolism.

Authors:  Tsai-Chun Lai; Meng-Chun Hu
Journal:  Sci Rep       Date:  2019-03-28       Impact factor: 4.379

Review 6.  Emerging Roles of DDB2 in Cancer.

Authors:  Pauline Gilson; Guillaume Drouot; Andréa Witz; Jean-Louis Merlin; Philippe Becuwe; Alexandre Harlé
Journal:  Int J Mol Sci       Date:  2019-10-18       Impact factor: 5.923

7.  DDB2 regulates DNA replication through PCNA-independent degradation of CDT2.

Authors:  Xiaojun Wu; Min Yu; Zhuxia Zhang; Feng Leng; Yue Ma; Ni Xie; Fei Lu
Journal:  Cell Biosci       Date:  2021-02-08       Impact factor: 7.133

8.  Exploiting Interdata Relationships in Prostate Cancer Proteomes: Clinical Significance of HO-1 Interactors.

Authors:  Sofia Lage-Vickers; Pablo Sanchis; Juan Bizzotto; Ayelen Toro; Agustina Sabater; Rosario Lavignolle; Nicolas Anselmino; Estefania Labanca; Alejandra Paez; Nora Navone; Maria P Valacco; Javier Cotignola; Elba Vazquez; Geraldine Gueron
Journal:  Antioxidants (Basel)       Date:  2022-01-31

Review 9.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

10.  Muscle-restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down-regulation of myogenin at the neuromuscular junction.

Authors:  Hsin-Hsiung Chen; Li-Kai Tsai; Kuan-Yu Liao; Tung-Chien Wu; Yun-Hsin Huang; Yuan-Chun Huang; Szu-Wei Chang; Pei-Yu Wang; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-04-02       Impact factor: 12.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.